WO2011147767A1 - Tamarind seed polysaccharide for use in the treatment of microbial infections - Google Patents
Tamarind seed polysaccharide for use in the treatment of microbial infections Download PDFInfo
- Publication number
- WO2011147767A1 WO2011147767A1 PCT/EP2011/058332 EP2011058332W WO2011147767A1 WO 2011147767 A1 WO2011147767 A1 WO 2011147767A1 EP 2011058332 W EP2011058332 W EP 2011058332W WO 2011147767 A1 WO2011147767 A1 WO 2011147767A1
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- tamarind seed
- seed polysaccharide
- treatment
- tsp
- antimicrobial
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/28—Asteraceae or Compositae (Aster or Sunflower family), e.g. chamomile, feverfew, yarrow or echinacea
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/75—Rutaceae (Rue family)
- A61K36/758—Zanthoxylum, e.g. pricklyash
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/77—Sapindaceae (Soapberry family), e.g. lychee or soapberry
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/14—Esters of carboxylic acids, e.g. fatty acid monoglycerides, medium-chain triglycerides, parabens or PEG fatty acid esters
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/26—Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/72—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
- A61K8/73—Polysaccharides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/96—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
- A61K8/97—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from algae, fungi, lichens or plants; from derivatives thereof
- A61K8/9783—Angiosperms [Magnoliophyta]
- A61K8/9789—Magnoliopsida [dicotyledons]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0014—Skin, i.e. galenical aspects of topical compositions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0034—Urogenital system, e.g. vagina, uterus, cervix, penis, scrotum, urethra, bladder; Personal lubricants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
- A61K9/006—Oral mucosa, e.g. mucoadhesive forms, sublingual droplets; Buccal patches or films; Buccal sprays
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/02—Stomatological preparations, e.g. drugs for caries, aphtae, periodontitis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/10—Antimycotics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q11/00—Preparations for care of the teeth, of the oral cavity or of dentures; Dentifrices, e.g. toothpastes; Mouth rinses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q17/00—Barrier preparations; Preparations brought into direct contact with the skin for affording protection against external influences, e.g. sunlight, X-rays or other harmful rays, corrosive materials, bacteria or insect stings
- A61Q17/005—Antimicrobial preparations
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q5/00—Preparations for care of the hair
- A61Q5/02—Preparations for cleaning the hair
Abstract
Description
Claims
Priority Applications (17)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
SG2012085791A SG185693A1 (en) | 2010-05-24 | 2011-05-23 | Tamarind seed polysaccharide for use in the treatment of microbial infections |
AU2011257387A AU2011257387B2 (en) | 2010-05-24 | 2011-05-23 | Tamarind seed polysaccharide for use in the treatment of microbial infections |
MX2012013606A MX341220B (en) | 2010-05-24 | 2011-05-23 | Tamarind seed polysaccharide for use in the treatment of microbial infections. |
RU2012149863/15A RU2571063C2 (en) | 2010-05-24 | 2011-05-23 | Polysaccharide of tamarind seed for application in treatment of microbial infections |
US13/699,406 US10206943B2 (en) | 2010-05-24 | 2011-05-23 | Antimicrobial compositions |
DK11724579.5T DK2575971T3 (en) | 2010-05-24 | 2011-05-23 | Combined plant extracts for use in the treatment of microbial infections |
BR112012029739A BR112012029739A2 (en) | 2010-05-24 | 2011-05-23 | tamarind seed polysaccharide for use in the treatment of microbial infections |
SI201130725T SI2575971T1 (en) | 2010-05-24 | 2011-05-23 | Combined plant extracts for use in the treatment of microbial infections |
CN201180025355.0A CN103025386B (en) | 2010-05-24 | 2011-05-23 | Be used for the treatment of the tamarind seed polysaccharide of infected by microbes |
CA2800382A CA2800382C (en) | 2010-05-24 | 2011-05-23 | Tamarind seed polysaccharide for use in the treatment of microbial infections |
ES11724579.5T ES2560953T3 (en) | 2010-05-24 | 2011-05-23 | Combined plant extracts for use in the treatment of microbial infections |
KR1020127030677A KR101878450B1 (en) | 2010-05-24 | 2011-05-23 | Tamarind seed polysaccharide for use in the treatment of microbial infections |
EP11724579.5A EP2575971B1 (en) | 2010-05-24 | 2011-05-23 | Combined plant extracts for use in the treatment of microbial infections |
JP2013511628A JP2013526594A (en) | 2010-05-24 | 2011-05-23 | Tamarind seed polysaccharide for use in the treatment of microbial infections |
PL11724579T PL2575971T3 (en) | 2010-05-24 | 2011-05-23 | Combined plant extracts for use in the treatment of microbial infections |
IL223176A IL223176A (en) | 2010-05-24 | 2012-11-22 | Tamarind seed polysaccharide for use in the treatment of microbial infections |
HK13110943.2A HK1183454A1 (en) | 2010-05-24 | 2013-09-25 | Tamarind seed polysaccharide for use in the treatment of microbial infections |
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
ITMI20100933 | 2010-05-24 | ||
ITMI2010A000933 | 2010-05-24 |
Publications (1)
Publication Number | Publication Date |
---|---|
WO2011147767A1 true WO2011147767A1 (en) | 2011-12-01 |
Family
ID=43477979
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/EP2011/058332 WO2011147767A1 (en) | 2010-05-24 | 2011-05-23 | Tamarind seed polysaccharide for use in the treatment of microbial infections |
Country Status (21)
Country | Link |
---|---|
US (1) | US10206943B2 (en) |
EP (1) | EP2575971B1 (en) |
JP (2) | JP2013526594A (en) |
KR (1) | KR101878450B1 (en) |
CN (1) | CN103025386B (en) |
AU (1) | AU2011257387B2 (en) |
BR (1) | BR112012029739A2 (en) |
CA (1) | CA2800382C (en) |
CL (1) | CL2012003266A1 (en) |
DK (1) | DK2575971T3 (en) |
ES (1) | ES2560953T3 (en) |
HK (1) | HK1183454A1 (en) |
HU (1) | HUE026862T2 (en) |
IL (1) | IL223176A (en) |
MX (1) | MX341220B (en) |
PL (1) | PL2575971T3 (en) |
PT (1) | PT2575971E (en) |
RU (1) | RU2571063C2 (en) |
SG (1) | SG185693A1 (en) |
SI (1) | SI2575971T1 (en) |
WO (1) | WO2011147767A1 (en) |
Cited By (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
ITMI20121917A1 (en) * | 2012-11-09 | 2014-05-10 | Velleja Res Srl | COMPOSITIONS FOR VAGINAL USE INCLUDING POLYSACCHARIDES FROM TAMARINDO |
WO2015158771A1 (en) | 2014-04-15 | 2015-10-22 | Novintethical Pharma Sa | Compositions based on xyloglucan and proteins for the treatment of intestinal disorders |
EP3103438A1 (en) | 2015-06-11 | 2016-12-14 | Novintethical Pharma SA | Topical nasal compositions containing xyloglucans for use as decongestans |
WO2022154772A1 (en) * | 2021-01-12 | 2022-07-21 | Almediko Saglik Urunleri Turizm Gida Sanayi Ve Ticaret Limited Sirketi | Anti-viral agent used in upper respiratory tract viral infections and the pharmaceutical composition comprising the same |
Families Citing this family (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN104844809B (en) * | 2015-03-25 | 2017-12-08 | 北京林业大学 | A kind of preparation method of tamarind seed polysaccharide gel |
WO2017173241A1 (en) | 2016-03-31 | 2017-10-05 | Gojo Industries, Inc. | Sanitizer composition with probiotic/prebiotic active ingredient |
US10806769B2 (en) | 2016-03-31 | 2020-10-20 | Gojo Industries, Inc. | Antimicrobial peptide stimulating cleansing composition |
DE102016207337A1 (en) | 2016-04-29 | 2017-11-02 | Henkel Ag & Co. Kgaa | Toothpaste for improving gingival adhesion |
CA3043748A1 (en) | 2016-11-23 | 2018-05-31 | Gojo Industries, Inc. | Sanitizer composition with probiotic/prebiotic active ingredient |
RU2754067C2 (en) * | 2018-05-18 | 2021-08-25 | Общество с ограниченной ответственностью "НИАРМЕДИК ФАРМА" | Antimicrobial composition based on polyphenols and polysaccharides, method for its preparation and application |
JP7138496B2 (en) * | 2018-07-06 | 2022-09-16 | 花王株式会社 | Antimicrobial peptide expression promoter |
Citations (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPH08231347A (en) * | 1995-02-24 | 1996-09-10 | Maruzen Pharmaceut Co Ltd | Hyaluronidase inhibitor and cosmetic |
WO1997028787A1 (en) | 1996-02-05 | 1997-08-14 | Farmigea S.P.A. | Ophthalmic solutions viscosified with tamarind seed polysaccharide |
FR2851469A1 (en) * | 2003-01-14 | 2004-08-27 | Jean Noel Thorel | Topical compositions containing a glucosidase inhibitor such as tamarind seed extract, for the prevention of skin irritation, especially around the lips |
WO2005063186A1 (en) * | 2003-12-30 | 2005-07-14 | Council Of Scientific & Industrial Research | Herbal oro-dental care composition and process for preparing the same |
WO2006123234A1 (en) * | 2005-05-19 | 2006-11-23 | Mcneil-Ppc, Inc. | Oral care compositions having improved substantivity |
JP2006325447A (en) * | 2005-05-24 | 2006-12-07 | Nisshin Pharma Inc | Anti-helicobacter pylori food and drink |
WO2006131262A1 (en) | 2005-06-06 | 2006-12-14 | Alfa Wassermann S.P.A. | Mucoadhesive xyloglucan-containing formulations useful in medical devices and in pharmaceutical formulations |
WO2009040847A2 (en) * | 2007-08-13 | 2009-04-02 | N.B.S. S.R.L. | Dermocosmetic compositions based on tamarind seed polysaccharide and vegetable extracts |
WO2009044423A1 (en) | 2007-10-02 | 2009-04-09 | Rmfa Trading S.A. | Ophthalmic compositions based on tamarind seed polysaccharide and hyaluronic acid |
Family Cites Families (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FR2728789A1 (en) * | 1995-01-03 | 1996-07-05 | Serobiologiques Lab Sa | USE OF EXTRACTS OF TAMARIN SEEDS ENRICHED IN XYLOGLYCANS AND A COSMETIC OR PHARMACEUTICAL PRODUCT CONTAINING SUCH EXTRACTS |
JP3593193B2 (en) * | 1995-11-14 | 2004-11-24 | 大日本製薬株式会社 | Hair restoration |
US6162393A (en) * | 1998-08-06 | 2000-12-19 | Ndt, Inc. | Contact lens and ophthalmic solutions |
CA2368574C (en) * | 1999-03-26 | 2008-08-12 | Sunstar Inc. | Compositions for preventing and treating type i allergy |
KR100943105B1 (en) * | 2001-08-10 | 2010-02-18 | 도레이 카부시키가이샤 | Polysaccharide-Containing Compositions and Use Thereof |
FR2843125B1 (en) * | 2002-08-02 | 2012-11-16 | Coletica | ACTIVE PRINCIPLES STIMULATING HUMAN BETA-DEFENSIVE TYPE 2 AND / OR TYPE 3, AND COSMETIC OR PHARMACEUTICAL COMPOSITIONS COMPRISING SUCH ACTIVE INGREDIENTS |
AU2004283091A1 (en) * | 2003-10-03 | 2005-05-06 | Allergan, Inc. | Compositions and methods comprising prostaglandin-related compounds and trefoil factor family peptides for the treatment of glaucoma with reduced hyperemia |
JP2005162663A (en) * | 2003-12-02 | 2005-06-23 | Asahi Denka Kogyo Kk | Base for skin |
ES2348984T3 (en) * | 2004-04-06 | 2010-12-21 | Novimmune S.A. | ATEROSCLEROSIS TREATMENT PROCEDURES. |
JP5134778B2 (en) * | 2006-03-10 | 2013-01-30 | 日清オイリオグループ株式会社 | Gel composition and pack cosmetic using the gel composition |
-
2011
- 2011-05-23 HU HUE11724579A patent/HUE026862T2/en unknown
- 2011-05-23 BR BR112012029739A patent/BR112012029739A2/en not_active Application Discontinuation
- 2011-05-23 CA CA2800382A patent/CA2800382C/en active Active
- 2011-05-23 SG SG2012085791A patent/SG185693A1/en unknown
- 2011-05-23 AU AU2011257387A patent/AU2011257387B2/en active Active
- 2011-05-23 KR KR1020127030677A patent/KR101878450B1/en active IP Right Grant
- 2011-05-23 SI SI201130725T patent/SI2575971T1/en unknown
- 2011-05-23 CN CN201180025355.0A patent/CN103025386B/en active Active
- 2011-05-23 US US13/699,406 patent/US10206943B2/en active Active
- 2011-05-23 RU RU2012149863/15A patent/RU2571063C2/en active
- 2011-05-23 EP EP11724579.5A patent/EP2575971B1/en active Active
- 2011-05-23 WO PCT/EP2011/058332 patent/WO2011147767A1/en active Application Filing
- 2011-05-23 PT PT117245795T patent/PT2575971E/en unknown
- 2011-05-23 JP JP2013511628A patent/JP2013526594A/en active Pending
- 2011-05-23 DK DK11724579.5T patent/DK2575971T3/en active
- 2011-05-23 ES ES11724579.5T patent/ES2560953T3/en active Active
- 2011-05-23 MX MX2012013606A patent/MX341220B/en active IP Right Grant
- 2011-05-23 PL PL11724579T patent/PL2575971T3/en unknown
-
2012
- 2012-11-22 CL CL2012003266A patent/CL2012003266A1/en unknown
- 2012-11-22 IL IL223176A patent/IL223176A/en active IP Right Grant
-
2013
- 2013-09-25 HK HK13110943.2A patent/HK1183454A1/en unknown
-
2016
- 2016-06-01 JP JP2016110020A patent/JP6239041B2/en active Active
Patent Citations (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPH08231347A (en) * | 1995-02-24 | 1996-09-10 | Maruzen Pharmaceut Co Ltd | Hyaluronidase inhibitor and cosmetic |
WO1997028787A1 (en) | 1996-02-05 | 1997-08-14 | Farmigea S.P.A. | Ophthalmic solutions viscosified with tamarind seed polysaccharide |
FR2851469A1 (en) * | 2003-01-14 | 2004-08-27 | Jean Noel Thorel | Topical compositions containing a glucosidase inhibitor such as tamarind seed extract, for the prevention of skin irritation, especially around the lips |
WO2005063186A1 (en) * | 2003-12-30 | 2005-07-14 | Council Of Scientific & Industrial Research | Herbal oro-dental care composition and process for preparing the same |
WO2006123234A1 (en) * | 2005-05-19 | 2006-11-23 | Mcneil-Ppc, Inc. | Oral care compositions having improved substantivity |
JP2006325447A (en) * | 2005-05-24 | 2006-12-07 | Nisshin Pharma Inc | Anti-helicobacter pylori food and drink |
WO2006131262A1 (en) | 2005-06-06 | 2006-12-14 | Alfa Wassermann S.P.A. | Mucoadhesive xyloglucan-containing formulations useful in medical devices and in pharmaceutical formulations |
WO2009040847A2 (en) * | 2007-08-13 | 2009-04-02 | N.B.S. S.R.L. | Dermocosmetic compositions based on tamarind seed polysaccharide and vegetable extracts |
WO2009044423A1 (en) | 2007-10-02 | 2009-04-09 | Rmfa Trading S.A. | Ophthalmic compositions based on tamarind seed polysaccharide and hyaluronic acid |
Non-Patent Citations (17)
Title |
---|
AGRAWAL A K ET AL: "EFFECT OF PIPER LONGUM LINN, ZINGIBER OFFICIANALIS LINN AND FERULA SPECIES ON GASTRIC ULCERATION AND SECRETION IN RATS", INDIAN JOURNAL OF EXPERIMENTAL BIOLOGY, COUNCIL OF SCIENTIFIC & INDUSTRIAL RESEARCH, IN, vol. 38, no. 10, 1 October 2000 (2000-10-01), pages 994 - 998, XP009001799, ISSN: 0019-5189 * |
AHUA ET AL: "Antileishmanial activities associated with plants used in the Malian traditional medicine", JOURNAL OF ETHNOPHARMACOLOGY, ELSEVIER SCIENTIFIC PUBLISHERS LTD, IE, vol. 110, no. 1, 8 February 2007 (2007-02-08), pages 99 - 104, XP005879691, ISSN: 0378-8741, DOI: 10.1016/J.JEP.2006.09.030 * |
ANONYMOUS: "Imli - Tamarind - Tamarindus indica - Flora - Trees - Haryana Online - India", 11 June 2009 (2009-06-11), pages 1 - 3, XP002618788, Retrieved from the Internet <URL:http://www.haryana-online.com/Flora/imli.htm> [retrieved on 20110125] * |
BURGALASSI S ET AL: "Effect of xyloglucan (tamarind seed polysaccharide) on conjunctival cell adhesion to laminin and on corneal epithelium wound healing.", EUROPEAN JOURNAL OF OPHTHALMOLOGY, vol. 10, no. 1, January 2000 (2000-01-01), pages 71 - 76, XP009143782, ISSN: 1120-6721 * |
DATABASE GNPD [online] Mintel; February 2008 (2008-02-01), ANONYMOUS: "Acne Spot Tx", XP002618792, retrieved from www.gnpd.com Database accession no. 850241 * |
DATABASE GNPD [online] Mintel; January 2009 (2009-01-01), ANONYMOUS: "Desert Bloom Ultrabalm", XP002618790, retrieved from www.gnpd.com Database accession no. 1054545 * |
DATABASE GNPD [online] Mintel; May 2008 (2008-05-01), ANONYMOUS: "Maximum Moisture Day Cream", XP002618791, retrieved from www.gnpd.com accession no. 911809 * |
DATABASE WPI Week 199646, Derwent World Patents Index; AN 1996-461243, XP002618798 * |
DATABASE WPI Week 200704, Derwent World Patents Index; AN 2007-029585, XP002618789 * |
GHELARDI EMILIA ET AL: "A mucoadhesive polymer extracted from tamarind seed improves the intraocular penetration and efficacy of rufloxacin in topical treatment of experimental bacterial keratitis", ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, vol. 48, no. 9, September 2004 (2004-09-01), pages 3396 - 3401, XP002618794, ISSN: 0066-4804 * |
MARCHETTI M ET AL: "Inhibition of Herpes Simplex Virus Infection by Negatively Charged and Neutral Carbohydrate Polymers", JOURNAL OF CHEMOTHERAPY, vol. 7, no. 2, 1995, pages 90 - 96, XP002618796, ISSN: 1120-009X * |
MASTROMARINO P ET AL: "Antiviral activity of natural and semisynthetic polysaccharides on the early steps of rubella virus infection", JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, vol. 39, no. 3, March 1997 (1997-03-01), pages 339 - 345, XP002618797, ISSN: 0305-7453 * |
PETRONIO M G ET AL: "IN VITRO EFFECT OF NATURAL AND SEMI-SYNTHETIC CARBOHYDRATE POLYMERS ON CHLAMYDIA TRACHOMATIS INFECTION", CHEMOTHERAPY, vol. 43, 1 January 1997 (1997-01-01), S. KARGER AG, CH, pages 211 - 217, XP000980521, ISSN: 0009-3157 * |
PIETROPAOLO ET AL: "Effect of natural and semisynthetic polymers on rabies virus infection in CER cells", RESEARCH IN VIROLOGY, vol. 144, 1 January 1993 (1993-01-01), ELSEVIER, PARIS, FR, pages 151 - 158, XP022352664, ISSN: 0923-2516, DOI: 10.1016/S0923-2516(06)80023-3 * |
SCHROEDER J-M ET AL: "MOLECULES IN FOCUS HUMAN BETA-DEFENSIN-2", INTERNATIONAL JOURNAL OF BIOCHEMISTRY AND CELL BIOLOGY, EXETER, GB, vol. 31, 1 January 1999 (1999-01-01), pages 645 - 651, XP002937538, ISSN: 1357-2725, DOI: 10.1016/S1357-2725(99)00013-8 * |
See also references of EP2575971A1 |
SINIBALDI L ET AL: "EFFECT OF BIOLOGICAL AND SYNTHETIC POLYMERS ON BK VIRUS INFECTIVITY AND HEMAGGLUTINATION", JOURNAL OF CHEMOTHERAPY, vol. 4, no. 1, 1992, pages 16 - 22, XP009143764, ISSN: 1120-009X * |
Cited By (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
ITMI20121917A1 (en) * | 2012-11-09 | 2014-05-10 | Velleja Res Srl | COMPOSITIONS FOR VAGINAL USE INCLUDING POLYSACCHARIDES FROM TAMARINDO |
WO2014072230A1 (en) * | 2012-11-09 | 2014-05-15 | Velleja Research S.R.L. | Compositions for vaginal use containing tamarind polysaccharides |
WO2015158771A1 (en) | 2014-04-15 | 2015-10-22 | Novintethical Pharma Sa | Compositions based on xyloglucan and proteins for the treatment of intestinal disorders |
EP3348273A1 (en) | 2014-04-15 | 2018-07-18 | Novintethical Pharma SA | Compositions based on xyloglucan and proteins for the treatment of intestinal disorders |
EP3103438A1 (en) | 2015-06-11 | 2016-12-14 | Novintethical Pharma SA | Topical nasal compositions containing xyloglucans for use as decongestans |
WO2022154772A1 (en) * | 2021-01-12 | 2022-07-21 | Almediko Saglik Urunleri Turizm Gida Sanayi Ve Ticaret Limited Sirketi | Anti-viral agent used in upper respiratory tract viral infections and the pharmaceutical composition comprising the same |
Also Published As
Publication number | Publication date |
---|---|
JP2013526594A (en) | 2013-06-24 |
SI2575971T1 (en) | 2016-02-29 |
US10206943B2 (en) | 2019-02-19 |
PT2575971E (en) | 2016-03-04 |
ES2560953T3 (en) | 2016-02-23 |
AU2011257387A1 (en) | 2012-12-13 |
JP2016153436A (en) | 2016-08-25 |
EP2575971A1 (en) | 2013-04-10 |
CA2800382A1 (en) | 2011-12-01 |
MX2012013606A (en) | 2012-12-17 |
BR112012029739A2 (en) | 2016-08-09 |
RU2012149863A (en) | 2014-06-27 |
CN103025386A (en) | 2013-04-03 |
HUE026862T2 (en) | 2016-07-28 |
RU2571063C2 (en) | 2015-12-20 |
IL223176A0 (en) | 2013-02-03 |
PL2575971T3 (en) | 2016-06-30 |
HK1183454A1 (en) | 2013-12-27 |
DK2575971T3 (en) | 2016-02-29 |
AU2011257387B2 (en) | 2016-10-13 |
IL223176A (en) | 2017-08-31 |
US20130149257A1 (en) | 2013-06-13 |
MX341220B (en) | 2016-08-10 |
CN103025386B (en) | 2015-12-16 |
KR20130108979A (en) | 2013-10-07 |
SG185693A1 (en) | 2012-12-28 |
KR101878450B1 (en) | 2018-07-13 |
CL2012003266A1 (en) | 2013-03-22 |
EP2575971B1 (en) | 2015-12-16 |
CA2800382C (en) | 2019-09-17 |
JP6239041B2 (en) | 2017-11-29 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AU2011257387B2 (en) | Tamarind seed polysaccharide for use in the treatment of microbial infections | |
US20060105000A1 (en) | Compositions for treating infected skin and mucous membrane comprising an anti-microbial agent and an essential oil | |
AU2011257388B2 (en) | Tamarind seed polysaccharide for use in the treatment of inflammatory diseases | |
WO2008140200A1 (en) | External compositions for the skin | |
US20170072024A1 (en) | Antimicrobial composition comprising a carbohydrate, glucose oxidase and zinc oxide | |
KR102413425B1 (en) | Feminine cleanser composition comprising beta glucan and vacuum filling ampoule comprising the same | |
RU2749710C1 (en) | Dental product in form of phytofilm | |
KR102445058B1 (en) | Roll type ointment improved usability and hygiene | |
TR2021005428T (en) | COMMIPHORA MOLMOL (MYRRH) RESIN EXTRACTS AND THEIR USE FOR THE PREVENTION, HEALING AND TREATMENT OF WOUNDS, MUCOOSITIS AND OTHER DISEASES |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
WWE | Wipo information: entry into national phase |
Ref document number: 201180025355.0 Country of ref document: CN |
|
121 | Ep: the epo has been informed by wipo that ep was designated in this application |
Ref document number: 11724579 Country of ref document: EP Kind code of ref document: A1 |
|
ENP | Entry into the national phase |
Ref document number: 2013511628 Country of ref document: JP Kind code of ref document: A Ref document number: 2800382 Country of ref document: CA Ref document number: 20127030677 Country of ref document: KR Kind code of ref document: A |
|
WWE | Wipo information: entry into national phase |
Ref document number: 223176 Country of ref document: IL Ref document number: 3652/KOLNP/2012 Country of ref document: IN Ref document number: MX/A/2012/013606 Country of ref document: MX |
|
WWE | Wipo information: entry into national phase |
Ref document number: 2011724579 Country of ref document: EP |
|
NENP | Non-entry into the national phase |
Ref country code: DE |
|
ENP | Entry into the national phase |
Ref document number: 2011257387 Country of ref document: AU Date of ref document: 20110523 Kind code of ref document: A |
|
ENP | Entry into the national phase |
Ref document number: 2012149863 Country of ref document: RU Kind code of ref document: A |
|
WWE | Wipo information: entry into national phase |
Ref document number: 13699406 Country of ref document: US |
|
REG | Reference to national code |
Ref country code: BR Ref legal event code: B01A Ref document number: 112012029739 Country of ref document: BR |
|
ENP | Entry into the national phase |
Ref document number: 112012029739 Country of ref document: BR Kind code of ref document: A2 Effective date: 20121122 |